Industry Alarmed By Third-Party Audit, Registry Provisions In Draft House Bills

A House subcommittee released nine pieces of draft FDA legislation June 6, including several provisions that mobilized device industry lobbyists to fight for changes

More from Archive

More from Medtech Insight